Merion (EWLU) Stock Price

Merion Price

NYSE·CLOSED
0.00
​
Market closed

Revenue at Merion has contracted by 19.6% per year over the past 7 years to 1.48 M USD. For Merion, the net margin of -80.8% is up versus -136.2% a few years ago.

Merion stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merion business model & stock analysis

Merion, Inc. is a biotechnology company, which engages in the provision of health and nutritional supplements and personal care products. The company is headquartered in West Covina, California and currently employs 13 full-time employees. The company went IPO on 2014-12-03. The firm is focused on selling its products on the Internet through its Website, www.dailynu.com. The firm marketed its seven individual nutritional supplement products and seven skin-care products on this Website. Its nutritional supplement products are made according to a micro molecular nutrition formula. Its nutritional supplements include Dibeier Granules & Oral, Longevity, US-Liver Gold, Cell Power, OPC Spa, Heart Power and O2 Cell Power. The firm's skin-care products focus on restoring epidermal calcium. The firm sells health and nutrition products manufactured by third parties that are already being sold by third party vendors. Its skin-care offerings include anti-aging cream, facial cream, facial serum, body lotion, sun protection, facial toner and facial cleanser.

Frequently asked questions about Merion

Converted at the current exchange rate, the Merion share trades at 0.00 EUR (0.00 USD).

The revenue cannot currently be calculated for Merion.

The profit cannot currently be calculated for Merion.

The P/E ratio cannot be calculated for Merion at the moment.

The P/S cannot be calculated for Merion currently.

The Eulerpool Quality Score for Merion is 2/10.

The ISIN of Merion is US58985T2024. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Merion is EWLU. The ticker symbol is used to trade Merion shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Industry
Personal Products
Number of shares
Employees
Revenue per Employee
113,928.31 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website merionus.com
Currency
USD
Initial public offering
Dec 3, 2014
ISIN
US58985T2024
Cusip
58985T103
Sedol
BF47TY8
Market capitalization
6,229.00 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
—
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
123.22 %
Last updated Oct 25, 2026, 1:51 PM

All fundamentals and in-depth analysis of Merion

Our stock analysis for Merion stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merion. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.